| Page 7 | Cafepharma

You are here

Primary tabs

FDA Grants Priority Review to Keytruda Combination Therapy for Metastatic Squamous Non-Small Cell Lung Cancer

Post date: July 2, 2018 - 9:16am

Spectrum's Rolontis Meets Primary Endpoint in Ph III Study for Neutropenia

Post date: June 29, 2018 - 9:58am

Kite Receives Positive Opinion from CHMP for Yescarta in Lymphoma

Post date: June 29, 2018 - 9:42am

Argenx Receives Milestone Payment from AbbVie for Preclinical Oncology Drug

Post date: June 28, 2018 - 9:57am

Arsanis Discontinues Ph II Trial of ASN100

Post date: June 28, 2018 - 9:43am

$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease

Post date: June 28, 2018 - 9:17am

Cedilla Therapeutics Adds Three Veterans to Enhance Discovery

Post date: June 28, 2018 - 9:05am

Microbiome report for week ending 6-24-18

Post date: June 27, 2018 - 7:51pm

FDA Grants Orphan Drug Status for Cannabidiol in the Treatment of Autoimmune Hepatitis

Post date: June 27, 2018 - 10:07am

FDA Grants Priority Review for Pfizer’s Glasdegib in Acute Myeloid Leukemia

Post date: June 27, 2018 - 9:49am

Pages